Mga Batayang Estadistika
| CIK | 1920092 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Gelteq Limited
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 29, 2025 |
Up to 4,000,000 Ordinary Shares Gelteq Limited Filed Pursuant to Rule 424(b)(3) Registration No. 333-288442 PROSPECTUS Up to 4,000,000 Ordinary Shares Gelteq Limited This prospectus relates to the resale, from time to time, of up to 4,000,000 of our ordinary shares, no par value (the “Ordinary Shares”), by the selling shareholder, Lincoln Park Capital Fund, LLC (“Lincoln Park”, or the “selling shareholder”). The Ordinary Shares being offered b |
|
| July 25, 2025 |
As filed with the Securities and Exchange Commission on July 25, 2025. As filed with the Securities and Exchange Commission on July 25, 2025. Registration Statement No. 333-288442 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English) |
|
| July 1, 2025 |
Industrious: MEMBERSHIP AGREEMENT Exhibit 10.24 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Industrious: MEMBERSHIP AGREEMENT Contract Date: November 19, 2024 This Membership Agreement (“Agreement”) is made by and between the Indust |
|
| July 1, 2025 |
As filed with the Securities and Exchange Commission on June 30, 2025. As filed with the Securities and Exchange Commission on June 30, 2025. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English) Australia 2834 N/A (Stat |
|
| July 1, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Gelteq Ltd. (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration |
|
| July 1, 2025 |
China eCommerce Accelerator & Social Commerce Program: Exhibit 10.23 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. China eCommerce Accelerator & Social Commerce Program: Design, Development & Deployment Statement of Work 02 December 2024 GELTEQ LTD Versio |
|
| July 1, 2025 |
Exhibit 10.25 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Employee Service Agreement Gelteq Ltd and Dr Paul Wynne Table of Contents 1. Parties 4 2. Purpose and Intent 4 3. Definitions and interpreta |
|
| July 1, 2025 |
Exhibit 10.28 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Convertible note deed Gelteq Limited Table of Contents Table of Contents i Dated 1 Parties 1 1. Defined terms and interpretation 1 2. Notes |
|
| June 30, 2025 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Exhibit 99.1 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and related notes as set forth in Exhibit 99.2 entitled “Condensed Consolidated Financial Statements for the Six Months Ended D |
|
| June 30, 2025 |
GELTEQ LIMITED INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.2 Gelteq Limited Contents 31 December 2024 GELTEQ LIMITED INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Pages Interim Report of Gelteq Limited for the Six Months Period Ended December 31, 2024 and 2023 Consolidated statement of profit or loss and other comprehensive income F-2 Consolidated statement of financial position F-3 Consolidated statement of changes in equity F-4 Consolidated stat |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-42373 Gelteq Limited (Registrant’s Name) Level 4 100 Albert Road South Melbourne VIC, 3025 Australia (Address of Principal Executive Offices) Indicate by c |
|
| March 14, 2025 |
Exhibit 10.1 PURCHASE AGREEMENT THIS PURCHASE AGREEMENT (the “Agreement”), dated effective as of March 13, 2025, is made by and between GELTEQ LIMITED, a company incorporated in Australia (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof. WHEREAS |
|
| March 14, 2025 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 13, 2025, is made by and between GELTEQ LIMITED, a company incorporated in Victoria, Australia (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwis |
|
| March 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-42373 Gelteq Limited (Registrant’s Name) Level 4 100 Albert Road South Melbourne VIC, 3025 Australia (Address of Principal Executive Offices) Indicate by |
|
| November 15, 2024 |
Exhibit 13.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Gelteq Limited (the “Registrant”) on Form 20-F for the year ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies pu |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 |
|
| November 15, 2024 |
Insider Trading Compliance Manual GELTEQ LIMITED Adopted: October 22, 2024 Exhibit 11.2 Insider Trading Compliance Manual GELTEQ LIMITED Adopted: October 22, 2024 In order to take an active role in the prevention of insider trading violations by its officers, directors, employees, consultants, attorneys, advisors and other related individuals, the Board of Directors (the “Board”) of Gelteq Limited, an Australian public limited company (the “Company”), has adopted the pol |
|
| November 15, 2024 |
Exhibit 12.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A)/15D-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Nathan J. Givoni, certify that: 1. I have reviewed this annual report on Form 20-F of Gelteq Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a mate |
|
| November 15, 2024 |
Exhibit 13.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Gelteq Limited (the “Registrant”) on Form 20-F for the year ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies pu |
|
| November 15, 2024 |
Exhibit 2.1 DESCRIPTION OF SECURITIES The following description of the material terms of the Ordinary Shares includes a summary of the specified terms of the Constitution and of applicable Australian law. The following description is intended as a summary only and does not constitute legal advice regarding those matters and should not be regarded as such. Unless stated otherwise, this description |
|
| November 15, 2024 |
Exhibit 97 GELTEQ LIMITED (ACN: 619 501 254) EXECUTIVE COMPENSATION CLAWBACK POLICY Adopted as of 21 October 2024 The Board of Directors (the “Board”) of Gelteq Limited (the “Company”) has adopted the following executive compensation clawback policy (this “Policy”). |
|
| November 15, 2024 |
Exhibit 12.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A)/15D-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Anthony W. Panther, certify that: 1. I have reviewed this annual report on Form 20-F of Gelteq Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a ma |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period |
|
| October 30, 2024 |
Gelteq Limited Closes US$5.2 Million Initial Public Offering Exhibit 99.2 Gelteq Limited Closes US$5.2 Million Initial Public Offering New York, New York – October 30, 2024 – Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering pric |
|
| October 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-42373 Gelteq Limited (Registrant’s Name) Level 4 100 Albert Road South Melbourne VIC, 3025 Australia (Address of Principal Executive Offices) Indicate b |
|
| October 30, 2024 |
Exhibit 4.1 Representative’s Warrant THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF SIX (6) MONTHS FOLLOWING THE COMMENCEMENT OF SALES OF ORDINARY SHARES IN THE OFFERING (AS DEFINED BELOW): (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER THAN OFFICERS OR PARTNERS OF THE BE |
|
| October 30, 2024 |
Exhibit 99.1 Gelteq Limited Prices US$5.2 Million Initial Public Offering Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS” New York, New York – October 28, 2024 – Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announce |
|
| October 30, 2024 |
Gelteq Limited UNDERWRITING AGREEMENT Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT October 28, 2024 The Benchmark Company, LLC 150 East 58th St., 17th Floor New York, NY 10155 Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Australian public limited company limited to shares (the “Company”), on the one hand, and The Benchmark Company, LLC (the “Representati |
|
| October 22, 2024 |
Gelteq Limited 1,300,000 Ordinary Shares PROSPECTUS Filed Pursuant to Rule 424(b)(4) Registration No. 333-280804 Gelteq Limited 1,300,000 Ordinary Shares This prospectus relates to the initial public offering in the United States of 1,300,000 Ordinary Shares, no par value, of Gelteq Limited, an Australian public limited company limited to shares, that will be issued by Gelteq Limited upon the closing of the initial public offering in the |
|
| October 17, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Gelteq Limited (Exact Name of Registrant as Specified in Its Charter) Australia Not Applicable (State of Incorporation or Organization) (I.R.S. Employer Identification No.) Level 100 Albert Road South Mel |
|
| September 26, 2024 |
VIA EDGAR September 26, 2024. U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C., 20549 Attn: Tamika Sheppard Re: Gelteq Limited Registration Statement on Form F-1, as amended File No. 333-280804 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), T |
|
| September 26, 2024 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia September 26, 2024 VIA EDGAR U. |
|
| September 25, 2024 |
Form of Representative’s Warrant Exhibit 1.2 Exhibit A Form of Representative’s Warrant THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF SIX (6) MONTHS FOLLOWING THE COMMENCEMENT OF SALES OF ORDINARY SHARES IN THE OFFERING (AS DEFINED BELOW): (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER THAN OFFICERS OR |
|
| September 25, 2024 |
As filed with the Securities and Exchange Commission on September 24, 2024. As filed with the Securities and Exchange Commission on September 24, 2024. Registration Statement No. 333-280804 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Eng |
|
| September 25, 2024 |
Gelteq Limited UNDERWRITING AGREEMENT Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT [], 2024 The Benchmark Company, LLC 150 East 58th St., 17th Floor New York, NY 10155 Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Australian public limited company limited to shares (the “Company”), on the one hand, and The Benchmark Company, LLC (the “Representative”), fo |
|
| September 25, 2024 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Exhibit 99.5 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia September 24, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attn: Tamika Sheppard Re: Gelteq Limited Registration Statement on Form F-1 Filed September 12, 2024 File No. 333-280804 Dear Ms. Sheppard, The und |
|
| September 24, 2024 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR September 24, 2024 U. |
|
| September 12, 2024 |
Exhibit 10.26 9 September 2024 Variation Agreement Between: A. Gelteq Limited (Gelteq); and B. ARC Group Limited (ARC). 1. The parties (Gelteq and ARC) entered into a Financial Services Advisory agreement dated 13 February 2024 (Agreement). 2. Terms capitalised herein, unless defined in this letter shall have the same meaning as in the Agreement. 3. Clause 4 of the Agreement states that the Agreem |
|
| September 12, 2024 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR September 12, 2024 U. |
|
| September 12, 2024 |
As filed with the Securities and Exchange Commission on September 12, 2024. As filed with the Securities and Exchange Commission on September 12, 2024. Registration Statement No. 333-280804 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Eng |
|
| September 12, 2024 |
Exhibit 10.25 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Convertible note deed Gelteq Limited Table of Contents 1. Defined terms and interpretation 3 2. Notes 8 3. Payment 9 4. Conversion 10 5. Rede |
|
| July 15, 2024 |
Exhibit 99.1 AMENDED AND RESTATED AUDIT AND RISK MANAGEMENT COMMITTEE CHARTER OF GELTEQ LIMITED Amended and Restated on February [ ], 2024 1. Purpose The Audit and Risk Management Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of Gelteq Limited (the “Company”) to assist the Board in monitoring: (1) the integrity of the annual and other financial statements of the |
|
| July 15, 2024 |
July 12, 2024 Via Edgar Transmission Ms. Laura Crotty/Mr. Tim Buchmiller Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Re: Gelteq Limited Request for Withdrawal of Post-Effective Amendment No. 1 to Registration Statement on Form F-1 Filed June 28, 2024 File No. 333-267169 Dear Ms. Crotty/Mr. Buchmiller, On June 28, 2024, Gelteq Li |
|
| July 15, 2024 |
委托加工合同 Entrusted Processing Contract Exhibit 10.1 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” 合同编号No.： Contract No.: 委托加工合同 Entrusted Processing Contract 甲方（委 托 方）： Party A (Client): Gelteq Pty Ltd (ACN: 619 501 254) 乙方（被委托方）： 蜡笔小新（福 |
|
| July 15, 2024 |
Gelteq Authorised Licensee Agreement – Pilot Program Exhibit 10.6 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” Gelteq Authorised Licensee Agreement – Pilot Program BETWEEN 1. Gelteq Pty Ltd ACN 619 501 254 (Gelteq); and 2. PacificPine Tennis Limited |
|
| July 15, 2024 |
Exhibit 10.16 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” Executive Service Agreement Gelteq Pty Ltd and Simon Hayden Szewach Table of Contents 1. Parties 1 2. Purpose and Intent 1 3. Definitions |
|
| July 15, 2024 |
Gelteq Authorised Licensee Agreement Exhibit 10.9 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Gelteq Authorised Licensee Agreement BETWEEN 1. Gelteq Ltd ACN 619 501 254 (Gelteq); and 2. Healthy Extracts Inc (Licensee). OPERATIVE PROVIS |
|
| July 15, 2024 |
WASATCH FORMULATION DEVELOPMENT AGREEMENT Exhibit 10.3 WASATCH FORMULATION DEVELOPMENT AGREEMENT This Formulation Development Agreement (“Agreement”) is entered into by and between Wasatch Product Development LLC, a Developer organized under the laws of Utah, having its principal place of business at 427 West 11950 South, Draper, Utah 84020 (“Developer”) and Gelteq Pty Ltd a Developer organized under the laws of Victoria, Australia, havin |
|
| July 15, 2024 |
Exhibit 10.25 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Convertible note deed Gelteq Limited Table of Contents 1. Defined terms and interpretation 3 2. Notes 8 3. Payment 9 4. Conversion 10 5. Rede |
|
| July 15, 2024 |
U.S. Securities and Exchange Commission Exhibit 16.1 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington DC 20549 Dear Sir/Madam, We have read and are in agreement with the statements in the first four paragraphs contained in the heading “Change in Registrant’s Certifying Accountant” contained in Gelteq Limited’s (“the Company”) Registration Statement on Form F-1 dated June 28, 2024 filed with the Securities and Exchan |
|
| July 15, 2024 |
Exhibit 3.1 CORPORATIONS ACT 2001 CONSTITUTION of GELTEQ LIMITED ACN 158 660 676 Adopted by shareholder special resolution on 12 April 2022 TABLE OF CONTENTS 1. Definitions 1 2. Interpretation 3 3. Share capital 5 4. Certificates 8 5. CHESS 9 6. Lien 10 7. Calls 12 8. Forfeiture of Shares 14 9. Transfer of Shares 15 10. Transmission of Shares 17 11. Alteration of capital 18 12. Variation or cancel |
|
| July 15, 2024 |
AGREEMENT FOR THE PROVISION OF OFFICE SPACE Exhibit 10.13 AGREEMENT FOR THE PROVISION OF OFFICE SPACE Lifestyle Breakthrough Holdings U/T (ABN 46 830 176 403) AND Gelteq Pty Ltd (ABN 31 619 501 254) This Agreement for the Provision of office space is made on the 30th day of October 2021 between: PARTIES Lifestyle Breakthrough Holdings U/T (ABN 46 830 176 403) (‘COMPANY’) of 647 Glenhuntly Rd, Caulfield VIC 3162 AND Gelteq Pty Ltd (ABN 31 61 |
|
| July 15, 2024 |
July 12, 2024 Via Edgar Transmission Ms. Laura Crotty/Mr. Tim Buchmiller Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Re: Gelteq Limited Registration Statement on Form F-1 Filed August 30, 2022 File No. 333-267169 Dear Ms. Crotty/Mr. Buchmiller, Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), Gelteq Limited (th |
|
| July 15, 2024 |
Exhibit 99.3 AMENDED AND RESTATED COMPENSATION COMMITTEE CHARTER OF GELTEQ LIMITED Amended and Restated on February [ ], 2024 1. PURPOSE The Compensation Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of Gelteq Limited (the “Company”) for the purposes of, among other things (a) discharging the Board’s responsibilities relating to the compensation of the Company’s |
|
| July 15, 2024 |
List of Subsidiaries of the Registrant Exhibit 21.1 List of Subsidiaries of the Registrant Entity Jurisdiction Nutrigel Pty Ltd Australia Nutrigel Unit Trust Australia Sport Supplements Pty Ltd Australia Sport Supplements Unit Trust Australia |
|
| July 15, 2024 |
As filed with the Securities and Exchange Commission on July 12, 2024. As filed with the Securities and Exchange Commission on July 12, 2024. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English) Australia 2834 N/A (Stat |
|
| July 15, 2024 |
Exhibit 10.23 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Convertible note deed Gelteq Limited Table of Contents 1. Defined terms and interpretation 3 2. Notes 8 3. Payment 9 4. Conversion 10 5. Rede |
|
| July 15, 2024 |
Exhibit 10.20 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Crestmont Investments Pty Ltd ATF Crestmont Investments Trust; (b) P |
|
| July 15, 2024 |
Monash Innovation Labs Companies on Campus - Licence Exhibit 10.22 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Monash Innovation Labs Companies on Campus - Licence Date 02-Feb-2024 | 2:49 PM AEDT By Monash University ABN 12 377 614 012 of Wellington Ro |
|
| July 15, 2024 |
Gelteq Authorised Licensee Agreement Exhibit 10.10 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Gelteq Authorised Licensee Agreement BETWEEN 1. Gelteq Ltd ACN 619 501 254 (Gelteq); and 2. Elbe Technologies Pty Ltd (Licensee). OPERATIVE |
|
| July 15, 2024 |
DEED OF VARIATION TO LOAN AGREEMENT Exhibit 10.15 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential DEED OF VARIATION TO LOAN AGREEMENT This Variation Deed is dated 3/1/2023 . Schedule Agreement: Loan Deed dated 20 January 2022 Parties to De |
|
| July 15, 2024 |
STRICTLY PRIVATE AND CONFIDENTIAL Exhibit 10.24 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential STRICTLY PRIVATE AND CONFIDENTIAL February 13th 2024, To: Gelteq Ltd Nathan Givoni- CEO From: ARC Group Limited Abraham Cinta - CEO FINANCIAL |
|
| July 15, 2024 |
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER GELTEQ LIMITED Exhibit 99.2 NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER OF GELTEQ LIMITED The responsibilities and powers of this Nominating and Corporate Governance Committee (the “Committee”) as delegated by the Board of Directors (the “Board”, and each director of the Board, a “Director”) of Gelteq Limited (the “Company”) are set forth in this charter. Whenever the Committee takes an action, it shal |
|
| July 15, 2024 |
CODE OF BUSINESS CONDUCT AND ETHICS Exhibit 14.1 CODE OF BUSINESS CONDUCT AND ETHICS 1. Introduction The Board of Directors (each member of the Board of Directors, a “Director”) of Gelteq Limited has adopted this code of business conduct and ethics (the “Code”), which is applicable to all directors, officers and employees of Gelteq Limited and its subsidiaries (the “Company”), and where relevant to consultants, secondees and contrac |
|
| July 15, 2024 |
Exhibit 10.5 "Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential." Variation Agreement THIS AGREEMENT is made between Monash University (ABN: 12 377 614 012) of Wellington Road, Clayton, Victoria (Monash) A |
|
| July 15, 2024 |
Exhibit 10.19 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Paramount Global Limited; (b) Gladwin Ventures Pty Ltd; (c) Jeff Oly |
|
| July 15, 2024 |
Exhibit 10.12 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” CONSULTING AGREEMENT THIS AGREEMENT (“Agreement”) is effective on the Effective Date of 6 September 2021. BETWEEN: SOSNA & CO INC., a corp |
|
| July 15, 2024 |
SCHEDULE 1 VISTRA SERVICE FEES ^ Exhibit 10.18 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential 5th February 2024 Nathan Givoni Chief Executive Officer Gelteq Limited 641 Glen Huntly Road CAULFIELD VIC 3162 Sent by email to [*****] Dear |
|
| July 15, 2024 |
Exhibit 99.4 Private & Confidential [Name] [Address] Dear [Name], Non - Executive Board Member Letter of Appointment On behalf of the Board of Directors I write to confirm the terms of your appointment as a Non-Executive Director of Gelteq Limited (ACN 619 501 254) (Company) as set out in this letter and its schedules (Letter). Gelteq Limited is a clinical and science-based company focused on deve |
|
| July 15, 2024 |
Exhibit 10.14 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Loan Agreement This Agreement is made on 20 January 2022. PARTIES 1. The Shareholder Listed in the Schedule (Lender); and 2. GELTEQ PTY LTD ACN 31 619 |
|
| July 15, 2024 |
Commissioned Processing Intellectual Property Power of Attorney Exhibit 10.2 "Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. 委托加工知识产权授权书 Commissioned Processing Intellectual Property Power of Attorney 授权人： (定作方) Licensor: Gelteq Pty Ltd (fixed party) 被授权人：蜡笔小新（福建）食 |
|
| July 15, 2024 |
Gelteq Authorised Licensee Agreement Exhibit 10.8 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Gelteq Authorised Licensee Agreement BETWEEN 1. Gelteq Ltd ACN 619 501 254 (Gelteq); and 2. Healthy Extracts Inc (Licensee). OPERATIVE PROVIS |
|
| July 15, 2024 |
Exhibit 10.4 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” MASTER RESEARCH SERVICES AGREEMENT THIS AGREEMENT is made on the…5th..day of December 2019 BETWEEN MONASH UNIVERSITY (ABN 12 377 614 012) o |
|
| July 15, 2024 |
Exhibit 10.17 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” Executive Service Agreement Gelteq Pty Ltd and Nathan Jacob Givoni Table of Contents 1. Parties 1 2. Purpose and Intent 1 3. Definitions a |
|
| July 15, 2024 |
Adjutor Healthcare Pty Ltd Gelteq Pty Ltd Master Services Agreement Exhibit 10.11 Parties Adjutor Healthcare Pty Ltd & Gelteq Pty Ltd Master Services Agreement SERVICES agreement dated the 1st day of November, in the year 2021. BETWEEN: Adjutor Healthcare Pty Ltd ACN 624 961 413 of Level 1, Suite 5, 796 High Street, Kew East, in the State of Victoria, 3102, Australia (Consultant) AND: Gelteq Pty Ltd ACN 619 501 254 of Level 7, 612-616 St Kilda Rd Melbourne VIC, 30 |
|
| July 15, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Gelteq Limited (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Ordinary Shares, no par value per share(1)(2) 457(o) 1,495,000 $ 5. |
|
| July 15, 2024 |
Key Terms – Private Label Agreement Exhibit 10.7 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” Key Terms – Private Label Agreement BETWEEN 1. Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, |
|
| July 15, 2024 |
DEED OF VARIATION TO LOAN AGREEMENT Exhibit 10.21 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential DEED OF VARIATION TO LOAN AGREEMENT This Variation Deed is dated 9/10/2023. Schedule Agreement: Loan Deed dated 20 January 2022 and Deed of V |
|
| June 28, 2024 |
U.S. Securities and Exchange Commission Exhibit 16.1 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington DC 20549 Dear Sir/Madam, We have read and are in agreement with the statements in the first four paragraphs contained in the heading “Change in Registrant’s Certifying Accountant” contained in Gelteq Limited’s (“the Company”) Registration Statement on Form F-1 dated June 28, 2024 filed with the Securities and Exchan |
|
| June 28, 2024 |
Exhibit 10.25 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Convertible note deed Gelteq Limited Table of Contents 1. Defined terms and interpretation 3 2. Notes 8 3. Payment 9 4. Conversion 10 5. Rede |
|
| June 28, 2024 |
As filed with the Securities and Exchange Commission on June 28, 2024. As filed with the Securities and Exchange Commission on June 28, 2024. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant nam |
|
| March 27, 2024 |
VIA EDGAR March 27, 2024 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C., 20549 Re: Gelteq Limited Registration Statement on Form F-1, as amended File No. 333-267169 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), R.F. Lafferty & Co., Inc., a |
|
| March 27, 2024 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia March 27, 2024 VIA EDGAR U. |
|
| February 29, 2024 |
As filed with the Securities and Exchange Commission on February 28, 2024. As filed with the Securities and Exchange Commission on February 28, 2024. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 8 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Engl |
|
| February 29, 2024 |
SCHEDULE 1 VISTRA SERVICE FEES ^ Exhibit 10.18 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential 5th February 2024 Nathan Givoni Chief Executive Officer Gelteq Limited 641 Glen Huntly Road CAULFIELD VIC 3162 Sent by email to [*****] Dear |
|
| February 29, 2024 |
Exhibit 10.24 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Convertible note deed Gelteq Limited Table of Contents 1. Defined terms and interpretation 3 2. Notes 8 3. Payment 9 4. Conversion 10 5. Rede |
|
| February 29, 2024 |
Exhibit 99.1 AMENDED AND RESTATED AUDIT AND RISK MANAGEMENT COMMITTEE CHARTER OF GELTEQ LIMITED Amended and Restated on February [ ], 2024 1. Purpose The Audit and Risk Management Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of Gelteq Limited (the “Company”) to assist the Board in monitoring: (1) the integrity of the annual and other financial statements of the |
|
| February 29, 2024 |
STRICTLY PRIVATE AND CONFIDENTIAL Exhibit 10.25 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential STRICTLY PRIVATE AND CONFIDENTIAL February 13th 2024, To: Gelteq Ltd Nathan Givoni- CEO From: ARC Group Limited Abraham Cinta - CEO FINANCIAL |
|
| February 29, 2024 |
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER GELTEQ LIMITED Exhibit 99.2 NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER OF GELTEQ LIMITED The responsibilities and powers of this Nominating and Corporate Governance Committee (the “Committee”) as delegated by the Board of Directors (the “Board”, and each director of the Board, a “Director”) of Gelteq Limited (the “Company”) are set forth in this charter. Whenever the Committee takes an action, it shal |
|
| February 29, 2024 |
DEED OF VARIATION TO LOAN AGREEMENT Exhibit 10.22 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential DEED OF VARIATION TO LOAN AGREEMENT This Variation Deed is dated 9/10/2023. Schedule Agreement: Loan Deed dated 20 January 2022 and Deed of V |
|
| February 29, 2024 |
Exhibit 99.3 AMENDED AND RESTATED COMPENSATION COMMITTEE CHARTER OF GELTEQ LIMITED Amended and Restated on February [ ], 2024 1. PURPOSE The Compensation Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of Gelteq Limited (the “Company”) for the purposes of, among other things (a) discharging the Board’s responsibilities relating to the compensation of the Company’s |
|
| February 29, 2024 |
Exhibit 10.21 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (“Agreement”) is entered into on the 15th day of October 2023 by and between Ocean Street Par |
|
| February 29, 2024 |
Gelteq Limited UNDERWRITING AGREEMENT Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT [], 2024 R.F. Lafferty & Co. Inc. 40 Wall Street, 19th Floor New York, NY 10005 Attn: Richard H. Kreger, Head of Investment Banking Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Australian public limited company limited to shares (the “Company”), on the one hand, and R.F. L |
|
| February 29, 2024 |
Monash Innovation Labs Companies on Campus - Licence Exhibit 10.23 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Monash Innovation Labs Companies on Campus - Licence Date 02-Feb-2024 | 2:49 PM AEDT By Monash University ABN 12 377 614 012 of Wellington Ro |
|
| December 5, 2023 |
As filed with the Securities and Exchange Commission on December 4, 2023. As filed with the Securities and Exchange Commission on December 4, 2023. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 7 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Engli |
|
| December 5, 2023 |
Exhibit 10.21 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (“Agreement”) is entered into on the 15th day of October 2023 by and between Ocean Street Par |
|
| December 5, 2023 |
DEED OF VARIATION TO LOAN AGREEMENT Exhibit 10.22 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential DEED OF VARIATION TO LOAN AGREEMENT This Variation Deed is dated 9/10/2023. Schedule Agreement: Loan Deed dated 20 January 2022 and Deed of V |
|
| December 5, 2023 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR December 4, 2023 U. |
|
| September 15, 2023 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR September 15, 2023 U. |
|
| September 15, 2023 |
As filed with the Securities and Exchange Commission on September 15, 2023. As filed with the Securities and Exchange Commission on September 15, 2023. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 6 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Eng |
|
| September 15, 2023 |
Gelteq Limited UNDERWRITING AGREEMENT Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT [], 2023 R.F. Lafferty & Co. Inc. 40 Wall Street, 19th Floor New York, NY 10005 Attn: Richard H. Kreger, Head of Investment Banking Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Australian public limited company limited to shares (the “Company”), on the one hand, and R.F. L |
|
| September 15, 2023 |
Form of Representative’s Warrant Exhibit 1.2 Exhibit A Form of Representative’s Warrant THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF ORDINARY SHARES IN THE OFFERING (AS DEFINED BELOW): (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER TH |
|
| August 3, 2023 |
As filed with the Securities and Exchange Commission on August 2, 2023. As filed with the Securities and Exchange Commission on August 2, 2023. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 5 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English |
|
| August 3, 2023 |
Gelteq Limited UNDERWRITING AGREEMENT Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT [], 2023 R.F. Lafferty & Co. Inc. 40 Wall Street, 19th Floor New York, NY 10005 Attn: Richard H. Kreger, Head of Investment Banking Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Australian public limited company limited to shares (the “Company”), on the one hand, and R.F. L |
|
| August 3, 2023 |
Form of Representative’s Warrant Exhibit 1.2 Exhibit A Form of Representative’s Warrant THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF ORDINARY SHARES IN THE OFFERING (AS DEFINED BELOW): (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER TH |
|
| August 3, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Gelteq Limited (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Underwriter’s Warrants(2)(3)(4) 457(g) — — — — — Equity Ordinary Shares underlying Underwriter’s Warrants(4) 457(g) 104,650 $ 6. |
|
| March 29, 2023 |
As filed with the Securities and Exchange Commission on March 29, 2023. As filed with the Securities and Exchange Commission on March 29, 2023. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English |
|
| March 29, 2023 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR March 29, 2023 U. |
|
| March 17, 2023 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR March 17, 2023 U. |
|
| March 17, 2023 |
Exhibit 99.8 Consent to be Named as a Director In connection with the filing by Gelteq Limited of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a director to the board of directors of Gelteq Limited in the Registra |
|
| March 17, 2023 |
Form of Underwriting Agreement (Draft) Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT [], 2023 Boustead Securities, LLC 6 Venture, Suite 395 Irvine, CA 92618 Attn: Keith Moore, Chief Executive Officer Attn: Daniel J. McClory, Managing Director Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Australian public limited company limited to shares (the “Company”), o |
|
| March 17, 2023 |
Executive Service Agreement, dated February 14, 2023, among Craig J. Young and Gelteq Ltd Exhibit 10.19 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential Executive Service Agreement Gelteq Ltd and Craig Young Table of Contents 1. Parties 1 2. Purpose and Intent 1 3. Definitions and interpretati |
|
| March 17, 2023 |
As filed with the Securities and Exchange Commission on March 17, 2023. As filed with the Securities and Exchange Commission on March 17, 2023. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English |
|
| February 6, 2023 |
Exhibit 10.8 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Gelteq Authorised Licensee Agreement BETWEEN 1. Gelteq Ltd ACN 619 501 254 (Gelteq); and 2. Healthy Extracts Inc (Licensee). OPERATIVE PROVIS |
|
| February 6, 2023 |
Exhibit 10.20 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Paramount Global Limited; (b) Gladwin Ventures Pty Ltd; (c) Jeff Oly |
|
| February 6, 2023 |
As filed with the Securities and Exchange Commission on February 3, 2023. As filed with the Securities and Exchange Commission on February 3, 2023. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Engli |
|
| February 6, 2023 |
Exhibit 10.9 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential. Gelteq Authorised Licensee Agreement BETWEEN 1. Gelteq Ltd ACN 619 501 254 (Gelteq); and 2. Healthy Extracts Inc (Licensee). OPERATIVE PROVIS |
|
| February 6, 2023 |
EX-10.10 4 ff12023a2ex10-10gelteq.htm GELTEQ AUTHORISED LICENSEE AGREEMENT, DATED JANUARY 23, 2023, BY AND AMONG ELBE TECHNOLOGIES PTY LTD AND GELTEQ LTD Exhibit 10.10 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or |
|
| February 6, 2023 |
Exhibit 10.21 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Crestmont Investments Pty Ltd ATF Crestmont Investments Trust; (b) P |
|
| February 6, 2023 |
Exhibit 10.16 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential DEED OF VARIATION TO LOAN AGREEMENT This Variation Deed is dated 3/1/2023 . Schedule Agreement: Loan Deed dated 20 January 2022 Parties to De |
|
| February 3, 2023 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR February 3, 2023 U. |
|
| December 9, 2022 |
As filed with the Securities and Exchange Commission on December 9, 2022. As filed with the Securities and Exchange Commission on December 9, 2022. Registration Statement No. 333-267169 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into Engli |
|
| December 9, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Gelteq Limited (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Underwriter’s Warrants(3)(5) 457(g) — — — — — Equity Ordinary Shares underlying Underwriter’s Warrants(5) 457(g) 18,711 $ 1. |
|
| December 9, 2022 |
Form of Underwriting Agreement (Draft) EX-1.1 2 ff12022a1ex1-1gelteq.htm FORM OF UNDERWRITING AGREEMENT Exhibit 1.1 Gelteq Limited UNDERWRITING AGREEMENT [], 2022 Boustead Securities, LLC 6 Venture, Suite 395 Irvine, CA 92618 Attn: Keith Moore, Chief Executive Officer Attn: Daniel J. McClory, Managing Director Ladies and Gentlemen: This underwriting agreement (this “Agreement”) constitutes the agreement between Gelteq Limited, an Austr |
|
| December 9, 2022 |
Executive Service Agreement, dated April 6, 2022, among Neale Java and Gelteq Pty Ltd EX-10.15 3 ff12022a1ex10-15gelteq.htm EXECUTIVE SERVICE AGREEMENT, DATED APRIL 6, 2022, AMONG NEALE JAVA AND GELTEQ PTY LTD Exhibit 10.15 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Executive Service Agreement |
|
| December 9, 2022 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR December 9, 2022 U. |
|
| August 30, 2022 |
Audit and Risk Management Committee Charter EX-99.1 23 ff12022ex99-1gelteqltd.htm AUDIT AND RISK MANAGEMENT COMMITTEE CHARTER Exhibit 99.1 AUDIT AND RISK MANAGMENT COMMITTEE CHARTER OF GELTEQ LIMITED 1. Purpose The Audit and Risk Management Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of Gelteq Limited (the “Company”) to assist the Board in monitoring: (1) the integrity of the annual and other financial s |
|
| August 30, 2022 |
Exhibit 99.6 Consent to be Named as a Director In connection with the filing by Gelteq Limited of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a director to the board of directors of Gelteq Limited in the Registra |
|
| August 30, 2022 |
Exhibit 10.15 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Paramount Global Limited; (b) Gladwin Ventures Pty Ltd; (c) Jeff Oly |
|
| August 30, 2022 |
Executive Service Agreement, dated April 28, 2022, among Nathan Jacob Givoni and Gelteq Pty Ltd Exhibit 10.14 ?Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.? Executive Service Agreement Gelteq Pty Ltd and Nathan Jacob Givoni Table of Contents 1. Parties 1 2. Purpose and Intent 1 3. Definitions a |
|
| August 30, 2022 |
EX-10.2 4 ff12022ex10-2gelteqltd.htm COMMISSIONED PROCESSING INTELLECTUAL PROPERTY POWER OF ATTORNEY CONTRACT, DATED AUGUST 24, 2021, BY AND AMONG LABIXIAOXIN (FUJIAN) FOODS INDUSTRIAL CO., LTD. AND GELTEQ PTY LTD Exhibit 10.2 "Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material |
|
| August 30, 2022 |
Compensation Committee Charter Exhibit 99.3 COMPENSATION COMMITTEE CHARTER OF GELTEQ LIMITED 1. PURPOSE The Compensation Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of Gelteq Limited (the “Company”) for the purposes of, among other things (a) discharging the Board’s responsibilities relating to the compensation of the Company’s chief executive officer (the “CEO”) and other executive officers |
|
| August 30, 2022 |
Exhibit 10.4 ?Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.? MASTER RESEARCH SERVICES AGREEMENT THIS AGREEMENT is made on the?5th..day of December 2019 BETWEEN MONASH UNIVERSITY (ABN 12 377 614 012) o |
|
| August 30, 2022 |
EX-10.8 10 ff12022ex10-8gelteqltd.htm MASTER SERVICES AGREEMENT, DATED NOVEMBER 1, 2021, BY AND AMONG ADJUTOR HEALTHCARE PTY LTD AND GELTEQ PTY LTD Exhibit 10.8 Parties Adjutor Healthcare Pty Ltd & Gelteq Pty Ltd Master Services Agreement SERVICES agreement dated the 1st day of November, in the year 2021. BETWEEN: Adjutor Healthcare Pty Ltd ACN 624 961 413 of Level 1, Suite 5, 796 High Street, Kew |
|
| August 30, 2022 |
Exhibit 10.6 ?Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.? Gelteq Authorised Licensee Agreement ? Pilot Program BETWEEN 1. Gelteq Pty Ltd ACN 619 501 254 (Gelteq); and 2. PacificPine Tennis Limited |
|
| August 30, 2022 |
Exhibit 10.3 WASATCH FORMULATION DEVELOPMENT AGREEMENT This Formulation Development Agreement (?Agreement?) is entered into by and between Wasatch Product Development LLC, a Developer organized under the laws of Utah, having its principal place of business at 427 West 11950 South, Draper, Utah 84020 (?Developer?) and Gelteq Pty Ltd a Developer organized under the laws of Victoria, Australia, havin |
|
| August 30, 2022 |
Subsidiaries of the Registrant Exhibit 21.1 List of Subsidiaries of the Registrant Entity Jurisdiction Nutrigel Pty Ltd Australia Nutrigel Unit Trust Australia Sport Supplements Pty Ltd Australia Sport Supplements Unit Trust Australia |
|
| August 30, 2022 |
Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited Level 4 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR August 30, 2022 U. |
|
| August 30, 2022 |
EX-3.1 2 ff12022ex3-1gelteqltd.htm CONSTITUTION OF OUR COMPANY Exhibit 3.1 CORPORATIONS ACT 2001 CONSTITUTION of GELTEQ LIMITED ACN 158 660 676 Adopted by shareholder special resolution on 12 April 2022 TABLE OF CONTENTS 1. Definitions 1 2. Interpretation 3 3. Share capital 5 4. Certificates 8 5. CHESS 9 6. Lien 10 7. Calls 12 8. Forfeiture of Shares 14 9. Transfer of Shares 15 10. Transmission of |
|
| August 30, 2022 |
Consulting Agreement, dated September 6, 2021, by and among Sosna & Co Inc. and Gelteq Pty Ltd Exhibit 10.9 ?Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.? CONSULTING AGREEMENT THIS AGREEMENT (?Agreement?) is effective on the Effective Date of 6 September 2021. BETWEEN: SOSNA & CO INC., a corpo |
|
| August 30, 2022 |
Variation Agreement, dated May 15, 2021, by and among Monash University and MyHypo Pty Ltd Exhibit 10.5 "Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential." Variation Agreement THIS AGREEMENT is made between Monash University (ABN: 12 377 614 012) of Wellington Road, Clayton, Victoria (Monash) A |
|
| August 30, 2022 |
As filed with the Securities and Exchange Commission on August 30, 2022. As filed with the Securities and Exchange Commission on August 30, 2022. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Gelteq Limited (Exact Name of Registrant as Specified in its Constitution) Not Applicable (Translation of Registrant name into English Australia 2834 N/A (State or Oth |
|
| August 30, 2022 |
Exhibit 99.4 Consent to be Named as a Director In connection with the filing by Gelteq Limited of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a director to the board of directors of Gelteq Limited in the Registra |
|
| August 30, 2022 |
Executive Service Agreement, dated April 28, 2022, among Simon Hayden Szewach and Gelteq Pty Ltd EX-10.13 15 ff12022ex10-13gelteqltd.htm EXECUTIVE SERVICE AGREEMENT, DATED APRIL 28, 2022, AMONG SIMON HAYDEN SZEWACH AND GELTEQ PTY LTD Exhibit 10.13 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” E |
|
| August 30, 2022 |
Form of Non-Executive Board Member Letter of Appointment EX-99.9 31 ff12022ex99-9gelteqltd.htm FORM OF NON-EXECUTIVE BOARD MEMBER LETTER OF APPOINTMENT Exhibit 99.9 Private & Confidential [Name] [Address] Dear [Name], Non - Executive Board Member Letter of Appointment On behalf of the Board of Directors I write to confirm the terms of your appointment as a Non-Executive Director of Gelteq Limited (ACN 619 501 254) (Company) as set out in this letter and |
|
| August 30, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form F-1 (Form Type) Gelteq Limited (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration Fee Fees to Be Paid Equity Ordinary Shares, no par value per share(1)(2) 457(o) 1,495,000 $ 5. |
|
| August 30, 2022 |
Nominating and Governance Committee Charter EX-99.2 24 ff12022ex99-2gelteqltd.htm NOMINATING AND GOVERNANCE COMMITTEE CHARTER Exhibit 99.2 NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER OF GELTEQ LIMITED The responsibilities and powers of this Nominating and Corporate Governance Committee (the “Committee”) as delegated by the Board of Directors (the “Board”, and each director of the Board, a “Director”) of Gelteq Limited (the “Compan |
|
| August 30, 2022 |
Code of Business Conduct and Ethics Exhibit 14.1 CODE OF BUSINESS CONDUCT AND ETHICS 1. Introduction The Board of Directors (each member of the Board of Directors, a ?Director?) of Gelteq Limited has adopted this code of business conduct and ethics (the ?Code?), which is applicable to all directors, officers and employees of Gelteq Limited and its subsidiaries (the ?Company?), and where relevant to consultants, secondees and contrac |
|
| August 30, 2022 |
Private Label Agreement, dated July 1, 2021, by and among Healthy Extracts Inc and Gelteq Pty Ltd Exhibit 10.7 ?Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.? Key Terms ? Private Label Agreement BETWEEN 1. Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, |
|
| August 30, 2022 |
Exhibit 10.12 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Loan Agreement This Agreement is made on 20 January 2022. PARTIES 1. The Shareholder Listed in the Schedule (Lender); and 2. GELTEQ PTY LTD ACN 31 619 |
|
| August 30, 2022 |
Exhibit 99.5 Consent to be Named as a Director In connection with the filing by Gelteq Limited of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a director to the board of directors of Gelteq Limited in the Registra |
|
| August 30, 2022 |
Consent of Hon. Philip Dalidakis Exhibit 99.7 Consent to be Named as a Director In connection with the filing by Gelteq Limited of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a director to the board of directors of Gelteq Limited in the Registra |
|
| August 30, 2022 |
EX-10.16 18 ff12022ex10-16gelteqltd.htm SHARE SALE AGREEMENT, DATED JUNE 13, 2021, BY AND AMONG CRESTMONT INVESTMENTS PTY LTD ATF CRESTMONT INVESTMENTS TRUST, PARAMOUNT GLOBAL LIMITED, GLADWIN VENTURES PTY LTD Exhibit 10.16 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and |
|
| August 30, 2022 |
Exhibit 10.10 ?Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.? CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (?Agreement?) is entered into on the 24 March 2022 by and between Ocean Street Partners, In |
|
| August 30, 2022 |
Exhibit 10.1 “Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.” 合同编号No.： Contract No.: 委托加工合同 Entrusted Processing Contract 甲方（委 托 方）： Party A (Client): Gelteq Pty Ltd (ACN: 619 501 254) 乙方（被委托方）： 蜡笔小新（福 |
|
| August 30, 2022 |
Exhibit 10.11 AGREEMENT FOR THE PROVISION OF OFFICE SPACE Lifestyle Breakthrough Holdings U/T (ABN 46 830 176 403) AND Gelteq Pty Ltd (ABN 31 619 501 254) This Agreement for the Provision of office space is made on the 30th day of October 2021 between: PARTIES Lifestyle Breakthrough Holdings U/T (ABN 46 830 176 403) (?COMPANY?) of 647 Glenhuntly Rd, Caulfield VIC 3162 AND Gelteq Pty Ltd (ABN 31 61 |
|
| August 30, 2022 |
Exhibit 99.8 Consent to be Named as a Director In connection with the filing by Gelteq Limited of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a director to the board of directors of Gelteq Limited in the Registra |
|
| June 30, 2022 |
Adjutor Healthcare Pty Ltd Gelteq Pty Ltd Master Services Agreement EX-10.8 9 filename9.htm Exhibit 10.8 Parties Adjutor Healthcare Pty Ltd & Gelteq Pty Ltd Master Services Agreement SERVICES agreement dated the 1st day of November, in the year 2021. BETWEEN: Adjutor Healthcare Pty Ltd ACN 624 961 413 of Level 1, Suite 5, 796 High Street, Kew East, in the State of Victoria, 3102, Australia (Consultant) AND: Gelteq Pty Ltd ACN 619 501 254 of Level 7, 612-616 St Kil |
|
| June 30, 2022 |
Gelteq Limited 100 Albert Road South Melbourne VIC, 3025 Gelteq Limited 100 Albert Road South Melbourne VIC, 3025 Australia VIA EDGAR June 29, 2022 U. |
|
| June 30, 2022 |
Key Terms – Private Label Agreement Exhibit 10.7 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Key Terms ? Private Label Agreement BETWEEN 1. Gelteq Pty Ltd (ACN 619 501 254) of c/o Level 7, 616-616 St Kilda Road, Melbourne, VIC 3004, Australia (G |
|
| June 30, 2022 |
EX-99.6 19 filename19.htm Exhibit 99.6 Private & Confidential [Name] [Address] Dear [Name], Non - Executive Board Member Letter of Appointment On behalf of the Board of Directors I write to confirm the terms of your appointment as a Non-Executive Director of Gelteq Limited (ACN 619 501 254) (Company) as set out in this letter and its schedules (Letter). Gelteq Limited is a clinical and science-bas |
|
| June 30, 2022 |
EX-10.13 14 filename14.htm Exhibit 10.13 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Executive Service Agreement Gelteq Pty Ltd and Simon Hayden Szewach Table of Contents 1. Parties 1 2. Purpose and Intent 1 3 |
|
| June 30, 2022 |
EX-10.12 13 filename13.htm Exhibit 10.12 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Loan Agreement This Agreement is made on 20 January 2022. PARTIES 1. The Shareholder Listed in the Schedule (Lender); and 2. |
|
| June 30, 2022 |
Gelteq Authorised Licensee Agreement – Pilot Program EX-10.6 7 filename7.htm Exhibit 10.6 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Gelteq Authorised Licensee Agreement – Pilot Program BETWEEN 1. Gelteq Pty Ltd ACN 619 501 254 (Gelteq); and 2. PacificPine Tenn |
|
| June 30, 2022 |
EX-10.14 15 filename15.htm Exhibit 10.14 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Executive Service Agreement Gelteq Pty Ltd and Nathan Jacob Givoni Table of Contents 1. Parties 1 2. Purpose and Intent 1 3. |
|
| June 30, 2022 |
WASATCH FORMULATION DEVELOPMENT AGREEMENT EX-10.3 4 filename4.htm Exhibit 10.3 WASATCH FORMULATION DEVELOPMENT AGREEMENT This Formulation Development Agreement (“Agreement”) is entered into by and between Wasatch Product Development LLC, a Developer organized under the laws of Utah, having its principal place of business at 427 West 11950 South, Draper, Utah 84020 (“Developer”) and Gelteq Pty Ltd a Developer organized under the laws of Vi |
|
| June 30, 2022 |
EX-10.4 5 filename5.htm Exhibit 10.4 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. MASTER RESEARCH SERVICES AGREEMENT THIS AGREEMENT is made on the…5th..day of December 2019 BETWEEN MONASH UNIVERSITY (ABN 12 37 |
|
| June 30, 2022 |
EX-10.9 10 filename10.htm Exhibit 10.9 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed CONSULTING AGREEMENT THIS AGREEMENT (“Agreement”) is effective on the Effective Date of 6 September 2021. BETWEEN: SOSNA & CO |
|
| June 30, 2022 |
AGREEMENT FOR THE PROVISION OF OFFICE SPACE EX-10.11 12 filename12.htm Exhibit 10.11 AGREEMENT FOR THE PROVISION OF OFFICE SPACE Lifestyle Breakthrough Holdings U/T (ABN 46 830 176 403) AND Gelteq Pty Ltd (ABN 31 619 501 254) This Agreement for the Provision of office space is made on the 30th day of October 2021 between: PARTIES Lifestyle Breakthrough Holdings U/T (ABN 46 830 176 403) (‘COMPANY’) of 647 Glenhuntly Rd, Caulfield VIC 3162 AN |
|
| June 30, 2022 |
As confidentially submitted to the Securities and Exchange Commission on June 30, 2022. |
|
| June 30, 2022 |
Commissioned Processing Intellectual Property Power of Attorney EX-10.2 3 filename3.htm Exhibit 10.2 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclose 委托加工知识产权授权书 Commissioned Processing Intellectual Property Power of Attorney 授权人： (定作方) Licensor: Gelteq Pty Ltd (fixed party) 被授权 |
|
| June 30, 2022 |
EX-10.5 6 filename6.htm Exhibit 10.5 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. Variation Agreement THIS AGREEMENT is made between Monash University (ABN: 12 377 614 012) of Wellington Road, Clayton, Victori |
|
| June 30, 2022 |
EX-10.15 16 filename16.htm Exhibit 10.15 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Paramount Global Limited; (b) Gladwin Ven |
|
| June 30, 2022 |
EX-10.10 11 filename11.htm Exhibit 10.10 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (“Agreement”) is entered into on the 24 March 2022 by and between Ocean Stree |
|
| June 30, 2022 |
委托加工合同 Entrusted Processing Contract EX-10.1 2 filename2.htm Exhibit 10.1 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed 合同编号No.： Contract No.: 委托加工合同 Entrusted Processing Contract 甲方（委 托 方）： Party A (Client): Gelteq Pty Ltd (ACN: 619 501 254) 乙方（被委 |
|
| June 30, 2022 |
EX-10.16 17 filename17.htm Exhibit 10.16 Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed Share Sale Agreement This agreement is dated 13 June 2021 (Agreement) BETWEEN: (a) Crestmont Investments Pty Ltd ATF Crestmo |
|
| March 31, 2022 |
As confidentially submitted to the Securities and Exchange Commission on March 31, 2022. |
